Maryland · Nonprofit
ESOPHAGEAL CANCER ACTION NETWORK INC
ESOPHAGEAL CANCER ACTION NETWORK INC (Maryland) receives grants from 38 organizations whose IRS filings report $598,338 to it, the largest being THE ROBERTO FOUNDATION ($300,000). 12 of them have funded it in more than one year.
- Revenue FY2024
- $617k
- Funders on record
- 38
- Grants received
- $598k
- Net assets
- $72k
What Esophageal Cancer Action Network Inc does
Mission
Ecan's mission is to save lives by 1) increasing awareness about the link between reflux disease and cancer, 2) promoting early detection, 3) supporting medical research into the prevention, detection, treatment and cure of esophageal cancer, and 4) providing patients and families with trustworthy information and compassionate support. This national nonprofit organization, based in baltimore, maryland, is led by a board of directors of top medical professionals, business leaders, and families that have been touched by esophageal cancer. History: ecan was founded in 2009 by former attorney and journalist mindy mintz mordecai and an impressive group of dedicated professionals after she lost the father of her two young children, and her husband of 14 years, to esophageal cancer. Angry and frustrated because she believes that her husband and thousands more like him might never have died had they been aware of the link between heartburn and cancer, mordecai is determined to prevent others f
As stated on its FY2024 Form 990.
Program
An active voice for patients at risk for and diagnosed with esophageal cancer ecan successfully advocated with the national cancer institute to change course and include esophageal cancer in its genome mapping project known as the cancer genome atlas (tcga) in 2011. The groundbreaking findings of that research led to the first fda approval of immunotherapy for esophageal cancer patients in 2021. Ecan's efforts to represent the interests of patients at risk for esophageal cancer has continued and, thus far, has resulted in the addition of nearly 20 million to federal budget for esophageal cancer. Ecan successfully led the charge to make sure that esophageal cancer researchers have access to a multi-million-dollar cancer research fund administered by the dept. Of defense. As a result, esophageal cancer researchers have been awarded millions of dollars in funding since 2021 and continue to be eligible to apply for funding every year. In 2024, ecan hosted its first in-person hill day where members of our ecan community had the opportunity to meet with legislators and their staff to advocate for the needs of esophageal cancer patients and those at risk for the disease, including the…
$569,894 spent$56,631 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $569,894.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $358k to $586k (+64%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 6%. Grants only. Government contracts and fees sit inside program revenue.
75% of ESOPHAGEAL CANCER ACTION NETWORK INC’s revenue is contributions — about as donation-reliant as the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
John C Lipham Md
Chairman
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 4 funders to 5 funders, grant income fell $105k → $11k.
7 of 38 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 32% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of ESOPHAGEAL CANCER ACTION NETWORK INC’s funders (the co-funder graph). Top 30 of 38 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
ESOPHAGEAL CANCER ACTION NETWORK INC leans on a few funders — its largest provides 50% of grant income and the top three 69%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
32% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ESOPHAGEAL CANCER ACTION NETWORK INC.
Largest funder’s share by year: 2017 96% · 2018 97% · 2019 81% · 2020 87% · 2021 40% · 2022 43% · 2023 46% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
27% of ESOPHAGEAL CANCER ACTION NETWORK INC's funders are still giving 3 years after their first grant; 32% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
ESOPHAGEAL CANCER ACTION NETWORK INC draws 100% of its grant income from funders outside Maryland, across 16 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $192k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ESOPHAGEAL CANCER ACTION NETWORK INC has grown faster than half of the 13,754 health nonprofits its size.
this organization peer median middle 50% of peers· 13,754 health nonprofits $100k–$1M, FY2024
Organizations like ESOPHAGEAL CANCER ACTION NETWORK INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Maryland
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
78% of spending goes to programs.
Governance
Public support
81%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 10 states
Screen this organization
A dated, signed PDF of the compliance screen for ESOPHAGEAL CANCER ACTION NETWORK INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ESOPHAGEAL CANCER ACTION NETWORK INC?
- ESOPHAGEAL CANCER ACTION NETWORK INC (Maryland) receives grants from 38 organizations whose IRS filings report $598,338 to it, the largest being THE ROBERTO FOUNDATION ($300,000). 12 of them have funded it in more than one year.
- How many funders does ESOPHAGEAL CANCER ACTION NETWORK INC have?
- IRS filings report 38 organizations giving $598,338 in grants to ESOPHAGEAL CANCER ACTION NETWORK INC, 12 of which have funded it in more than one year.
- Who is the largest funder of ESOPHAGEAL CANCER ACTION NETWORK INC?
- THE ROBERTO FOUNDATION is the largest funder on record, with $300,000 in grants. The full list of funders is on this page.
- How can an organization like ESOPHAGEAL CANCER ACTION NETWORK INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Maryland. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Esophageal Cancer Action Network →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 38 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing